Wageningen, 16 November 2017- Alloksys Life Sciences announced today that its international APPIRED lll clinical study has started with inclusion of the first patient in Eindhoven, the Netherlands. Patients undergoing…
Wageningen, 23 October 2017- Alloksys Life Sciences announced today that Kevin Driscoll has been appointed to its Supervisory Board. Dr. Driscoll is a proven Healthcare executive with 30 years experience…
Bunnik, The Netherlands September 1 2016 – Alloksys Life Sciences BV, a biopharma SME based in The Netherlands, has been granted an Innovation Cedit (’Innovatiekrediet’) of 3.4 million EUR by…
This is the largest investment by a Singapore pharmaceutical manufacturer for clinical trial development ICM Pharma will have exclusive manufacturing and marketing rights for RESCAP® used in cardiothoracic surgery for…
Alloksys and AMRIF appoints Koos van Haasteren as CEO to gear up for RESCAP® platform development Utrecht, 28 December 2015 – The Dutch based Alloksys Life Sciences BV and AMRIF…